危重症成人氧中毒
本文综述危重症成人补充氧的获益与危害证据:动物实验显示高FiO2导致呼吸衰竭和早期死亡,1960年代人体尸检所称的弥漫性肺泡损伤可能由呼吸机相关肺损伤等混杂因素解释;普通危重症人群观察性研究关于高氧暴露与病死率的相关性不一致,而心脏骤停等特定人群研究提示追求超生理性PaO2可能有害;近期在较窄生理范围内设定动脉氧合目标的随机试验中,两项较小试验结论相反,但两项最大试验显示限制性与宽松性氧合目标组临床结局无差异,提示任一种策略均合理。
要点
- 两项最大的成人危重症动脉氧合目标随机试验显示,限制性氧合目标与宽松性氧合目标组临床结局无差异,提示任一种策略均合理。
- 两项较小随机试验关于动脉氧合目标的结论相反,证据尚不一致。
- 普通危重症人群的观察性研究显示较高氧暴露与较高病死率相关,但该发现并不一致。
- 心脏骤停等特定人群的研究提示,以超生理性PaO2为目标可能有害。
- 动物实验一致显示,暴露于高FiO2可导致呼吸衰竭和早期死亡。
适用人群与场景
- 危重症成人患者,氧疗是该人群最常见的干预之一。
- 特定人群如心脏骤停患者,研究提示以超生理性PaO2为目标可能有害。
研究设计与关键结果
- 动物实验一致显示,暴露于高FiO2可导致呼吸衰竭和早期死亡。
- 1960年代人体尸检研究称发现弥漫性肺泡损伤的组织学证据,但同期呼吸机相关肺损伤和/或其他急性肺损伤原因可能解释这些发现。
- 普通危重症人群的观察性研究显示较高氧暴露与较高病死率相关,但该发现并不一致。
- 两项较小随机试验关于动脉氧合目标的结论相反。
- 两项最大的随机试验显示,接受限制性与宽松性氧合目标的研究组之间临床结局无差异,提示任一种策略均合理。
- 作者认为,某些策略可能对某些亚组人群有益,这仍是重要的在研领域。
证据类型、等级与局限
- 证据类型:综述。
- 证据来源包括动物实验、1960年代人体尸检研究、观察性研究、特定人群研究及随机临床试验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 两项最大的随机试验显示限制性与宽松性氧合目标临床结局无差异,提示任一种策略均合理。
- 心脏骤停等特定人群的研究提示,以超生理性PaO2为目标可能有害。
- 作者认为,某些策略可能对某些亚组人群有益,这仍是重要的在研领域。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Oxygen supplementation is one of the most common interventions in critically ill patients. Despite over a century of data suggesting both beneficial and detrimental effects of supplemental oxygen, optimal arterial oxygenation targets in adult patients remain unclear. Laboratory animal studies have consistently showed that exposure to a high FiO2 causes respiratory failure and early death. Human autopsy studies from the 1960s purported to provide histologic evidence of pulmonary oxygen toxicity in the form of diffuse alveolar damage. However, concomitant ventilator-induced lung injury and/or other causes of acute lung injury may explain these findings. Although some observational studies in general populations of critically adults showed higher mortality in association with higher oxygen exposures, this finding has not been consistent. For some specific populations, such as those with cardiac arrest, studies have suggested harm from targeting supraphysiologic PaO2 levels. More recently, randomized clinical trials of arterial oxygenation targets in narrower physiologic ranges were conducted in critically ill adult patients. Although two smaller trials came to opposite conclusions, the two largest of these trials showed no differences in clinical outcomes in study groups that received conservative versus liberal oxygen targets, suggesting that either strategy is reasonable. It is possible that some strategies are of benefit in some subpopulations, and this remains an important ongoing area of research. Because of the ubiquity of oxygen supplementation in critically ill adults, even small treatment effects could have a large impact on a global scale.
参考来源
- Hochberg CH, Semler MW, Brower RG, et al. Oxygen Toxicity in Critically Ill Adults. Am J Respir Crit Care Med. 2021. PMID: 34086536. doi:10.1164/rccm.202102-0417CI
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。